Ribavirin
For Laboratory Research Only. Not for Clinical or Personal Use.
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Ribavirin
Description :
Ribavirin (ICN-1229) is an antiviral agent against a broad spectrum of viruses including HCV, HIVl, and RSV. Ribavirin also has anti-orthopoxvirus and anti-variola activities.Product Name Alternative :
RibasphereUNSPSC :
12352005Hazard Statement :
H341, H360Target :
Antibiotic; HCV; Orthopoxvirus; RSVType :
Reference compoundRelated Pathways :
Anti-infectionApplications :
COVID-19-anti-virusField of Research :
Infection; CancerAssay Protocol :
https://www.medchemexpress.com/ribavirin.htmlConcentration :
10mMPurity :
99.96Solubility :
DMSO : 100 mg/mL (ultrasonic) |H2O : 100 mg/mL (ultrasonic)Smiles :
O[C@H]1[C@@H](O)[C@H](N2N=C(C(N)=O)N=C2)O[C@@H]1COMolecular Formula :
C8H12N4O5Molecular Weight :
244.21Precautions :
H341, H360References & Citations :
[1]Abdel-Hamid NM, et al. Synergistic Effects of Jerusalem Artichoke in Combination with Pegylated Interferon Alfa-2a and Ribavirin Against Hepatic Fibrosis in Rats. Asian Pac J Cancer Prev. 2016;17 (4) :1979-85.|[2]Refaat B, et al. The effects of pegylated interferon-α and ribavirin on liver and serum concentrations of activin-A and follistatin in normal Wistar rat: a preliminary report. BMC Res Notes. 2015 Jun 26;8:265|[3]Savic D, et al. Ribavirin shows immunomodulatory effects on activated microglia. Immunopharmacol Immunotoxicol. 2014 Dec;36 (6) :433-41|[4]Chang J, et al. Combination of α-glucosidase inhibitor and ribavirin for the treatment of dengue virus infection in vitro and in vivo. Antiviral Res. 2011 Jan;89 (1) :26-34|[5]Robert O Baker, et al. Potential antiviral therapeutics for smallpox, monkeypox and other orthopoxvirus infections. Antiviral Res. 2003 Jan;57 (1-2) :13-23.Shipping Conditions :
Room TemperatureStorage Conditions :
-20°C, 3 years; 4°C, 2 years (Powder)Scientific Category :
Reference compound1Clinical Information :
LaunchedCAS Number :
[36791-04-5]

